This inventor holds 1 USPTO granted patent. Top assignee: Interpace Diagnostics Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Anna Szafransak-Schwarzbach: Innovator in Pancreatic Disease Detection
Introduction
Anna Szafransak-Schwarzbach is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of pancreatic diseases. Her innovative work focuses on utilizing microRNA profiles to distinguish between pancreatic cancer and benign pancreatic conditions.
Latest Patents
Anna holds a patent for "Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease." This patent outlines methods and compositions for identifying a specific miRNA profile associated with pancreatic disease, which can be instrumental in assessing patient conditions.
Career Highlights
Anna Szafransak-Schwarzbach is affiliated with Interpace Diagnostics Corporation, where she applies her expertise in molecular diagnostics. Her work has been pivotal in advancing the understanding of pancreatic diseases and improving diagnostic accuracy.
Collaborations
Throughout her career, Anna has collaborated with notable colleagues, including Alex Adai and Bernard Andruss. These partnerships have enhanced her research and contributed to the development of innovative diagnostic methods.
Conclusion
Anna Szafransak-Schwarzbach is a trailblazer in the field of pancreatic disease detection, with her patent and collaborative efforts paving the way for advancements in medical diagnostics. Her contributions are vital for improving patient outcomes in the realm of pancreatic health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile